7Baggers
The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.

ARCA biopharma, Inc
(NASDAQ:ABIO) 

ABIO stock logo

ARCA biopharma, Inc., a clinical-stage biopharmaceutical company, develops and commercializes genetically targeted therapies for cardiovascular diseases. Its lead product candidates are Recombinant Nematode Anticoagulant Protein c2 (rNAPc2) (AB201), which is in Phase 2 clinical trial for the treatme...

Founded: 2004
Full Time Employees: 13
Sector: Healthcare
Industry: Biotechnology

Share this website to your friends
ARCA biopharma Days Payable Outstanding ttm (DPO)
202303 202304 202305 202306 202307 202308 202309 202310 202311 202312 202401 202402 202403 202404 0170.05340.1510.15680.21850.261,020.311,190.36
ARCA biopharma Op Cashflow Per Share ttm
202209 202210 202211 202212 202301 202302 202303 202304 202305 202306 202307 202308 202309 202310 202311 202312 202401 202402 202403 202404 -0.82-0.7-0.58-0.47-0.35-0.23-0.120
ARCA biopharma Free Cashflow Per Share ttm
202209 202210 202211 202212 202301 202302 202303 202304 202305 202306 202307 202308 202309 202310 202311 202312 202401 202402 202403 202404 -0.82-0.7-0.59-0.47-0.35-0.23-0.120
ARCA biopharma Cash Per Share ttm
202209 202210 202211 202212 202301 202302 202303 202304 202305 202306 202307 202308 202309 202310 202311 202312 202401 202402 202403 202404 00.460.921.381.842.32.763.22
ARCA biopharma (GAAP) P/E ratio ttm
202209 202210 202211 202212 202301 202302 202303 202304 202305 202306 202307 202308 202309 202310 202311 202312 202401 202402 202403 202404 -10.26-8.79-7.33-5.86-4.4-2.93-1.470
ARCA biopharma P/B ratio ttm
202209 202210 202211 202212 202301 202302 202303 202304 202305 202306 202307 202308 202309 202310 202311 202312 202401 202402 202403 202404 00.170.350.520.690.861.041.21
No extra charts and metrics for this ticker.